Rapport Therapeutics, Inc. (RAPP)
41.95
+0.56
(+1.35%)
USD |
NASDAQ |
Sep 17, 16:00
41.92
-0.03
(-0.08%)
After-Hours: 20:00
Rapport Therapeutics Market Cap : 2.012B for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 2.012B |
| September 16, 2026 | 1.985B |
| September 15, 2026 | 2.047B |
| September 14, 2026 | 2.110B |
| September 11, 2026 | 2.092B |
| September 10, 2026 | 2.084B |
| September 09, 2026 | 2.105B |
| September 08, 2026 | 2.210B |
| September 04, 2026 | 2.195B |
| September 03, 2026 | 2.285B |
| September 02, 2026 | 2.335B |
| September 01, 2026 | 2.329B |
| August 31, 2026 | 2.334B |
| August 28, 2026 | 2.339B |
| August 27, 2026 | 2.438B |
| August 26, 2026 | 2.518B |
| August 25, 2026 | 2.454B |
| August 24, 2026 | 2.366B |
| August 21, 2026 | 2.313B |
| August 20, 2026 | 2.295B |
| August 19, 2026 | 2.353B |
| August 18, 2026 | 2.350B |
| August 17, 2026 | 2.322B |
| August 14, 2026 | 2.274B |
| August 13, 2026 | 2.271B |
| Date | Value |
|---|---|
| August 12, 2026 | 2.289B |
| August 11, 2026 | 2.341B |
| August 10, 2026 | 2.253B |
| August 07, 2026 | 2.181B |
| August 06, 2026 | 2.223B |
| August 05, 2026 | 2.035B |
| August 04, 2026 | 2.024B |
| August 03, 2026 | 1.956B |
| July 31, 2026 | 1.959B |
| July 30, 2026 | 2.045B |
| July 29, 2026 | 1.957B |
| July 28, 2026 | 2.006B |
| July 27, 2026 | 2.014B |
| July 24, 2026 | 1.945B |
| July 23, 2026 | 1.978B |
| July 22, 2026 | 1.976B |
| July 21, 2026 | 2.035B |
| July 20, 2026 | 1.922B |
| July 17, 2026 | 2.038B |
| July 16, 2026 | 1.919B |
| July 15, 2026 | 1.909B |
| July 14, 2026 | 1.982B |
| July 13, 2026 | 1.941B |
| July 10, 2026 | 1.996B |
| July 09, 2026 | 2.010B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.732B |
| Corcept Therapeutics, Inc. | 12.40B |
| Veru, Inc. | 40.75M |
| Johnson & Johnson | 650.75B |
| Eli Lilly & Co. | 1.085T |
Market Cap Related Metrics
| PS Ratio | 94.19 |
| PEG Ratio | -0.5862 |
| Price to Book Value | 4.757 |
| Price | 41.95 |
| Earnings Yield | -7.25% |
| PEGY Ratio | -0.5862 |